scholarly article | Q13442814 |
P356 | DOI | 10.3892/OR.2010.1079 |
10.3892/OR.2010.1090 | ||
P932 | PMC publication ID | 3041593 |
P698 | PubMed publication ID | 21152872 |
P50 | author | Jae J Song | Q60313016 |
P2093 | author name string | Yong J Lee | |
So Y Kim | |||
Bo K Sun | |||
Hoan N Nguyen | |||
Joo-Hang Kim | |||
Seeun Oh | |||
Sujin Choi | |||
Hye J Choi | |||
P2860 | cites work | Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2. | Q24292137 |
Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38) | Q24295263 | ||
Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 | ||
Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
Differential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily | Q24654366 | ||
Signal transduction by the JNK group of MAP kinases | Q28142592 | ||
A link between metastasis and resistance to apoptosis of variant small cell lung carcinoma | Q28239805 | ||
Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting [...] | Q28280257 | ||
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death | Q29620021 | ||
Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. | Q33940485 | ||
MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis | Q33996873 | ||
c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment | Q34250032 | ||
Mammalian Sterile20-like kinase 1 and the regulation of apoptosis | Q34322331 | ||
Survival-promoting functions of 14-3-3 proteins | Q34797105 | ||
TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality. | Q35009467 | ||
The CD95(APO-1/Fas) DISC and beyond | Q35091401 | ||
14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
Mitogen-activated protein kinases in apoptosis regulation | Q35743118 | ||
Targeting death receptors in cancer with Apo2L/TRAIL. | Q35834889 | ||
Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. | Q36477045 | ||
TRAIL signalling: decisions between life and death. | Q36778214 | ||
Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells | Q39842626 | ||
Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption | Q40144580 | ||
Evidence for two modes of development of acquired tumor necrosis factor-related apoptosis-inducing ligand resistance. Involvement of Bcl-xL. | Q40207500 | ||
Differential activation of the JNK signal pathway by UV irradiation and glucose deprivation | Q40222274 | ||
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. | Q40279060 | ||
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand | Q40361361 | ||
Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms | Q40560857 | ||
Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death | Q40594593 | ||
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathways | Q40992331 | ||
Anti-cell death activity promotes pulmonary metastasis of melanoma cells | Q41104241 | ||
JNK (c-Jun N-terminal kinase) and p38 activation in receptor-mediated and chemically-induced apoptosis of T-cells: differential requirements for caspase activation | Q42057774 | ||
The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis | Q45711503 | ||
TRAIL-induced death of human adult oligodendrocytes is mediated by JNK pathway. | Q46736950 | ||
MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta | Q80860090 | ||
P433 | issue | 2 | |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | 537-544 | |
P577 | publication date | 2010-12-07 | |
P1433 | published in | Oncology Reports | Q7092098 |
P1476 | title | MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylation | |
P478 | volume | 25 |
Q48859144 | 14-3-3β Depletion Drives a Senescence Program in Glioblastoma Cells Through the ERK/SKP2/p27 Pathway. |
Q34487441 | CCR7 regulates cell migration and invasion through JAK2/STAT3 in metastatic squamous cell carcinoma of the head and neck |
Q37003894 | Cells surviving fractional killing by TRAIL exhibit transient but sustainable resistance and inflammatory phenotypes |
Q47291846 | DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells. |
Q37407344 | HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4). |
Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
Q39305649 | Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra. |
Q34333852 | Role of Bcl-xL/Beclin-1 in synergistic apoptotic effects of secretory TRAIL-armed adenovirus in combination with mitomycin C and hyperthermia on colon cancer cells |
Q35946035 | STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. |
Q28384960 | TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways |
Q33993124 | The role of chemoattractant receptors in shaping the tumor microenvironment. |
Q34123342 | p38 MAPK inhibition suppresses the TLR-hypersensitive phenotype in FANCC- and FANCA-deficient mononuclear phagocytes |
Search more.